5,669
Participants
Start Date
March 11, 2019
Primary Completion Date
February 28, 2020
Study Completion Date
December 30, 2020
Opt-in; Receive offer to order self-sampling kit
Women in the opt-in arm receive an offer to order a HPV self-sampling kit, in addition to information about the study. Women who order, receive a kit that includes a self-sampling brush (Evalyn, Rovers Medical Devices), with instructions for use and a pre-paid envelope for returning the brush for HPV testing. The women are also informed that they can attend ordinary screening, i.e. performed by a physician. Women who choose self-sampling and test positive for high-risk HPV will be 1:1 allocated to follow-up by their general practitioner or a gynecologist. Women who test negative for high-risk HPV return to the ordinary screening program
Opt-out; Receive self-sampling kit unsolicited
Women in the opt-out arm receive the self-sampling kit directly, without having ordered it themselves. The kit has the same contents, and the follow-up is the same, as that described for the opt-in arm.
Control; Receive open reminder to be screened by physician
Similar to the procedure of the national screening program, women in the control arm receive a reminder to be screened by their general practitioner, and continues in the ordinary screening program
Cancer Registry of Norway, Oslo
University Hospital, Akershus
OTHER
University of Oslo
OTHER
University of Bergen
OTHER
Albert Einstein College of Medicine
OTHER
Norwegian Institute of Public Health
OTHER_GOV
Oslo University Hospital
OTHER